Human papillomavirus (HPV) is the most common sexually transmitted infection (STI)
worldwide. In the United States, approximately 13 million new infections occur annually, half …

Epidemiological studies have shown that HPV-related diseases are the most prevalent
sexually transmitted infections. In this context, this report will present various clinical cases …

Background The quadrivalent human papillomavirus vaccine (qHPV) is FDA-approved for
use in males 9 to 26 years old to prevent anogenital condyloma. The objective of this study …

Anogenital warts and laryngeal papillomas are two most important benign tumors
etiologically linked with HPV. In the study, which included both the largest number of …

Background: Cryotherapy cannot destroy subclinical human papillomavirus‐infected cells of
condylomata acuminata (CA). The topical application of aminolevulinic acid (ALA) results in …

This study describes the preparation and evaluation of two formulations, a hydrogel and a
nanostructured system, containing ketorolac tromethamine as an anti-inflammatory agent for …

Background Aminolaevulinic acid-mediated photodynamic therapy (ALA-PDT) is used to
treat condyloma acuminata (CA), yielding a high clearance rate and low recurrence rate …

Objectives: To prospectively examine the association between human papilloma virus (HPV)
colonization of the colonic mucosa and the development of colorectal polyps (CRPs), and …

Background Genital infections with low‐risk (LR) and high‐risk (HR) human papillomavirus
(HPV) genotypes are associated with ano‐genital condylomata and anal squamous cell …

BACKGROUND: Men who have sex with men have increased prevalence of both human
papillomavirus and anogenital condyloma. OBJECTIVE: Risk factors for multiple treatment …